company background image
RENATA logo

Renata DSE:RENATA Stock Report

Last Price

৳673.40

Market Cap

৳77.2b

7D

9.0%

1Y

-44.7%

Updated

21 Jun, 2024

Data

Company Financials +

RENATA Stock Overview

Renata Limited manufactures, markets, distributes, and exports human pharmaceuticals, animal health medicines, nutritionals, and vaccines in Bangladesh.

RENATA fundamental analysis
Snowflake Score
Valuation1/6
Future Growth4/6
Past Performance1/6
Financial Health3/6
Dividends2/6

Renata PLC Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Renata
Historical stock prices
Current Share Price৳673.40
52 Week High৳1,217.90
52 Week Low৳608.30
Beta0.029
11 Month Change0.45%
3 Month Change-20.20%
1 Year Change-44.71%
33 Year Change-39.31%
5 Year Change-19.76%
Change since IPO23,007.24%

Recent News & Updates

Recent updates

Shareholder Returns

RENATABD PharmaceuticalsBD Market
7D9.0%4.2%3.0%
1Y-44.7%-20.5%-24.2%

Return vs Industry: RENATA underperformed the BD Pharmaceuticals industry which returned -20.5% over the past year.

Return vs Market: RENATA underperformed the BD Market which returned -24.2% over the past year.

Price Volatility

Is RENATA's price volatile compared to industry and market?
RENATA volatility
RENATA Average Weekly Movement4.3%
Pharmaceuticals Industry Average Movement6.8%
Market Average Movement5.4%
10% most volatile stocks in BD Market7.6%
10% least volatile stocks in BD Market3.4%

Stable Share Price: RENATA's share price has been volatile over the past 3 months.

Volatility Over Time: RENATA's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19727,119Syed S. Kabirwww.renata-ltd.com

Renata Limited manufactures, markets, distributes, and exports human pharmaceuticals, animal health medicines, nutritionals, and vaccines in Bangladesh. Its pharmaceutical products include antimicrobials, anti-hypertensive, anti-angina, anti-diabetic, eye-ear and topical preparation, antigout, NSAID, anti-spasmodic, steroid, anti-osteoporotic, anti-allergic, cardiovascular, CNS, hormone, anti-cancer, oxytocic, anti-fibrinolytic, anti-asthma, expectorant, oral rehydration saline, narcotic analgesic, antipyretic/analgesic, antiemetic, anesthetic, antiviral, and other products. The company also offers lipid lowering, antiulcer, anti-parasitic and anti-protozoal, anti-fungal, anti-tuberculosis, and gastroprokinetic agents; and vitamins and minerals, and amino acid supplements.

Renata PLC Fundamentals Summary

How do Renata's earnings and revenue compare to its market cap?
RENATA fundamental statistics
Market cap৳77.24b
Earnings (TTM)৳2.29b
Revenue (TTM)৳36.47b

33.7x

P/E Ratio

2.1x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
RENATA income statement (TTM)
Revenue৳36.47b
Cost of Revenue৳22.25b
Gross Profit৳14.22b
Other Expenses৳11.92b
Earnings৳2.29b

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)20.00
Gross Margin38.99%
Net Profit Margin6.29%
Debt/Equity Ratio52.2%

How did RENATA perform over the long term?

See historical performance and comparison

Dividends

0.9%

Current Dividend Yield

31%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.